✦ LIBER ✦

Insufficient Evidence to Conclude Whether Anti–Tumor Necrosis Factor Therapy Increases the Risk of Lymphoma in Crohn's Disease

✍ Scribed by Peyrin–Biroulet, Laurent; Colombel, Jean–Frederic; Sandborn, William J.

Book ID: 123150106
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 131 KB
Volume: 7
Category: Article
ISSN: 1542-3565
DOI: 10.1016/j.cgh.2009.05.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of Lymphoma Associated With Combina

Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis

✍ Siegel, Corey A.; Marden, Sadie M.; Persing, Sarah M.; Larson, Robin J.; Sands, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 406 KB

Perioperative Anti-Tumor Necrosis Factor

Perioperative Anti-Tumor Necrosis Factor Therapy Does Not Increase the Rate of Early Postoperative Complications in Crohn’s Disease

✍ Basil S. Nasir; Eric J. Dozois; Robert R. Cima; John H. Pemberton; Bruce G. Wolf 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 188 KB

Increased Effectiveness of Early Therapy

Increased Effectiveness of Early Therapy With Anti-Tumor Necrosis Factor-α vs an Immunomodulator in Children With Crohn's Disease

✍ Walters, Thomas D.; Kim, Mi-Ok; Denson, Lee A.; Griffiths, Anne M.; Dubinsky, Ma 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 212 KB

PG117 REALWORLD DOSING OF ANTI-TUMOR NEC

PG117 REALWORLD DOSING OF ANTI-TUMOR NECROSIS FACTOR THERAPIES IN THE TREATMENT OF ADULTS WITH CROHN'S DISEASE

✍ H Waters; T Meekins; A Bewtra; RS McKenzie; B Tang; CT Piech; N Papandrikopoulou 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Exam 1: Increased Effectiveness of Early

Exam 1: Increased Effectiveness of Early Therapy With Anti–Tumor Necrosis Factor-α vs an Immunomodulator in Children With Crohn's Disease

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Anti–tumor necrosis factor α therapy and

Anti–tumor necrosis factor α therapy and the risk of lymphoma in rheumatoid arthritis: No clear answer

✍ Deborah P. M. Symmons; Alan J. Silman 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB 👁 1 views

The authors are the principal investigators of the British Society of Rheumatology (BSR) Biologics Register. The BSR receives financial support for the Register from the manufacturers of biologic agents currently licensed for use in the treatment of patients with inflammatory rheumatic diseases. The